-
1
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study)
Published 2025-01-01Subjects: Get full text
Article -
2
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study
Published 2024-11-01Subjects: Get full text
Article -
3
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand
Published 2025-06-01Subjects: “…Gepants…”
Get full text
Article -
4
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
Published 2025-06-01Subjects: “…Gepants…”
Get full text
Article -
5
Combining treatments for migraine prophylaxis: the state-of-the-art
Published 2024-12-01Subjects: Get full text
Article -
6
Longitudinal assessment of migraine burden in resistant and refractory migraine – Data from the prospective REFINE study
Published 2025-08-01Subjects: Get full text
Article -
7
Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway
Published 2025-03-01Subjects: “…gepants…”
Get full text
Article -
8
Variant angina associated with a CGRP receptor antagonist: a case report
Published 2025-05-01Subjects: Get full text
Article -
9
Gepants in Primary Care: A Targeted Approach to Acute and Preventive Treatment of Migraine
Published 2025-06-01Subjects: Get full text
Article -
10
Hallmarks of primary headache: part 1 – migraine
Published 2024-10-01Subjects: Get full text
Article -
11
Comprehensive preventive treatments for episodic migraine: a systematic review of randomized clinical trials
Published 2025-08-01Subjects: Get full text
Article -
12
-
13